The ọgwụ 'Eufillin' (mbadamba). Ntuziaka maka ojiji

Medicine "Eufillin" na ọtụtụ-eji ọgwụ na-eme. Karịsịa, ọgwụ na-kenyere obi, akpa ume pathologies. Ọma pụtara na ọbara ọrịa.

Ihe e ji mara nkwadebe "Eufillin" (mbadamba) iji ntụziaka na-egosi ya ikike ịmụba arịa, rụọ ha permeability.

Na ọgwụgwọ nke akpa ume ọrịa agwọ ọrịa mmemmem sputum, dyspnea irè aka. Ọgwụ "Eufillin" na-atụ aro maka iwepụ bronchospasm. Pụtara ike ime ka uru ahụ nke akụkụ okuku ume na usoro, belata contractility. Nkwadebe "Eufillin" irè n'ihi na ọ bụghị nanị na mwepụ nke apịajighị apịaji na bronchi, ma ọbara arịa na opi mgbailu.

The agwọ ọrịa nwere ike kwụsịtụ na iga nke calcium ion site na ọwa cell membranes.

Nkwadebe "Eufillin" (mbadamba) iji ntụziaka na-egosi na o nwere a nwayọọ mamịrị (mamịrị) mmetụta, na-ebelata platelet aggregation. The agwọ ọrịa nwere a na-akpali akpali utịp ke akụkụ okuku ume na center, enhances ike na ugboro ole nke contractions nke obi.

The bioavailability nke ọgwụ mgbe ndinọ ọnụ - iri asatọ na otu narị percent. The agwọ ọrịa bụ mkpokọta 60% ibikwa na plasma-edozi. Pụtara "Eufillin" (mbadamba) iji ntụziaka e dere ozi dị otú ahụ fọrọ nke nta kpamkpam (iri itoolu percent) na-metabolized na imeju. The ọkara ndụ oge bụ banyere awa ise ka otu ụbọchị.

Pụtara "Eufillin" (mbadamba) ntụziaka ntuziaka na-atụ aro broncho-okpo syndrome, ọrịa nke akụkụ okuku ume center. Dị ka akụkụ nke a jikọtara ọgwụgwọ nke ọgwụ kenyere ọbara odida na ọbara ọrịa nke ụbụrụ.

The onunu ogwu kpebisiri ike n'otu n'otu. Dị ka a na-achị, ọ na-atụ aro n'oge ụbọchị atọ na anọ, otu ma ọ bụ mbadamba nkume abụọ pụtara "Eufillin". Ọ bụrụ na achọrọ (site dọkịta ahụ ọgwụ) onunu ogwu nwere ike ụba na etiti oge nke abụọ ma ọ bụ ụbọchị atọ iru chọrọ ọgwụgwọ nrụpụta.

N'itinye ọgwụ yiri ka ibelata agụụ. O nwere ike ịbụ isi ọwụwa, ọgbụgbọ, tachycardia, vomiting, na-ewe iwe obi ọnụego, albuminuria. Mgbe ụfọdụ, ndị oriri nke ọgwụ hụrụ hematuria. The likelihood nke mmetụta na-atụle, na nfụkasị Jeremaya (ọkụ ọkụ ma ọ bụ itching). Na obere okwu, e nwere ike ịbụ a hypoglycemia, na-akawanye njọ ọnyá, convulsive ala.

Pụtara "Eufillin" na-contraindicated na rịaworo, nnukwu obi ọdịda, obi n'afọ iri na ụma na-anaghị ekwe, Akwụkwụ na-adọ. Ọ bụghị na-atụ aro agwọ ọrịa maka imebi na akụrụ ma ọ bụ imeju owụt agwa hypersensitivity ka aminophylline.

Ịkpachara anya ga-gosipụtara mgbe anamde ibọ ọgwụ "Eufillin" na-arịa ọrịa na a fever nke edoghị si malite, ndị ọrịa na ndị agadi.

Ọ na-hụrụ na agwọ ọrịa nwere ike isi mụbaa urinary uric acid.

Iji ọgwụ "Eufillin" n'oge ime na ara na-ekwe naanị ma ọ bụrụ na gosiri. Na nke a, nhọpụta a na-eme site na a dọkịta. The ọkachamara ga nyochaa ọnọdụ nke ime, lactating ọrịa n'oge nile ọgwụ.

Na n'otu oge ojiji nke ọgwụ ọjọọ, "Eufillin" ọgwụ "Salbutamol" na "Terbutaline" Noa ha bronhodillatiruyuschaya ọrụ.

The jikọtara iji ọgwụ na beta-blockers nwere ike kpasuo bronchospasm.

Pụtara "Eufillin". ntọhapụ Ụdị

The ọgwụ na-arụpụtara dị ka injectable ngwọta (dị ka igba ogwu n'akwara na intramuscular). Dị na mbadamba na suppositories "Eufillin".

Tupu iji ọgwụ ọjọọ eme ihe kwesịrị ịkpọ na a dọkịta.